| scholarly article | Q13442814 |
| P50 | author | Kerstin Reimers | Q125992098 |
| Vesna Bucan | Q89184217 | ||
| P2093 | author name string | Peter M Vogt | |
| Andrea Lazaridis | |||
| Nadjib Dastagir | |||
| Khaled Dastagir | |||
| P2860 | cites work | LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death | Q22010722 |
| Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment | Q24319929 | ||
| Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells | Q24685483 | ||
| Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT | Q28283545 | ||
| The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration | Q30494570 | ||
| Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma | Q33184109 | ||
| Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. | Q34427178 | ||
| Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma | Q34476202 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease | Q35597411 | ||
| Silencing of anti-apoptotic transmembrane protein lifeguard sensitizes solid tumor cell lines MCF-7 and SW872 to perifosine-induced cell death activation | Q36135521 | ||
| Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression | Q36615251 | ||
| The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis | Q37108466 | ||
| Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies | Q37379857 | ||
| Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells | Q39124362 | ||
| The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues. | Q39723123 | ||
| The growth-hormone inducible transmembrane protein (Ghitm) belongs to the Bax inhibitory protein-like family | Q40036972 | ||
| Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells | Q40340216 | ||
| Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression | Q40377414 | ||
| FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35. | Q40395370 | ||
| Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. | Q40812295 | ||
| Fas expression and function in normal and malignant breast cell lines. | Q41158790 | ||
| LFG: a candidate apoptosis regulatory gene family | Q43552548 | ||
| Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways | Q43612811 | ||
| The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. | Q43918657 | ||
| Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy | Q44772620 | ||
| Diagnostic and prognostic value of fas and telomeric-repeat binding factor-1 genes in adrenal tumors | Q46052425 | ||
| Regulation of dermal fibroblast dedifferentiation and redifferentiation during wound healing and limb regeneration in the Axolotl | Q46706134 | ||
| Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma. | Q47617874 | ||
| Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy. | Q51987890 | ||
| Prognostic relevance of altered Fas (CD95)-system in human breast cancer | Q61900217 | ||
| Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells | Q62604220 | ||
| FasL:Fas ratio--a prognostic factor in breast carcinomas | Q73519176 | ||
| Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer | Q81677197 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 1335-1340 | |
| P577 | publication date | 2014-07-25 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Role of lifeguard β-isoform in the development of breast cancer | |
| P478 | volume | 32 |
Search more.